688139 海尔生物
已收盘 11-20 15:00:00
资讯
新帖
简况
海尔生物(688139)11月18日主力资金净卖出24.58万元
证券之星 · 11-19 08:29
海尔生物(688139)11月18日主力资金净卖出24.58万元
股市必读:海尔生物(688139)11月18日董秘有最新回复
证券之星 · 11-19 04:00
股市必读:海尔生物(688139)11月18日董秘有最新回复
海尔生物:已将科技伦理纳入治理体系
证券之星 · 11-18 15:33
海尔生物:已将科技伦理纳入治理体系
股市必读:海尔生物(688139)11月17日披露最新机构调研信息
证券之星 · 11-18 02:17
股市必读:海尔生物(688139)11月17日披露最新机构调研信息
海尔生物:11月17日接受机构调研,航长投资、中金公司参与
证券之星 · 11-17
海尔生物:11月17日接受机构调研,航长投资、中金公司参与
【机构调研记录】新华基金调研海尔生物
证券之星 · 11-12
【机构调研记录】新华基金调研海尔生物
海尔生物(688139)11月10日股东户数1.41万户,较上期减少0.93%
证券之星 · 11-11
海尔生物(688139)11月10日股东户数1.41万户,较上期减少0.93%
海尔生物:截至2026年11月10日,公司股东总数为14,096户
证券之星 · 11-11
海尔生物:截至2026年11月10日,公司股东总数为14,096户
治疗进入细胞时代!海尔生物以AI与低温创新引领产业变革
证券之星 · 11-07
治疗进入细胞时代!海尔生物以AI与低温创新引领产业变革
海尔生物:11月3日接受机构调研,宝盈基金、国盛证券等多家机构参与
证券之星 · 11-04
海尔生物:11月3日接受机构调研,宝盈基金、国盛证券等多家机构参与
海尔生物新注册《高通量器官芯片微肿瘤药敏测试人工智能平台V1.0》项目的软件著作权
证券之星 · 11-04
海尔生物新注册《高通量器官芯片微肿瘤药敏测试人工智能平台V1.0》项目的软件著作权
股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》
证券之星 · 11-04
股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》
海尔生物(688139)10月31日股东户数1.42万户,较上期减少0.83%
证券之星 · 11-03
海尔生物(688139)10月31日股东户数1.42万户,较上期减少0.83%
海尔生物:截至2026年10月31日,公司股东总数为14,228户
证券之星 · 11-03
海尔生物:截至2026年10月31日,公司股东总数为14,228户
海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,11月02日股价上涨1.66%
证券之星 · 11-02
海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,11月02日股价上涨1.66%
海尔生物已回购约251.16万股,耗资约7894.69万元
同花顺 · 11-02
海尔生物已回购约251.16万股,耗资约7894.69万元
海尔生物获得发明专利授权:“移液工作站”
证券之星 · 11-02
海尔生物获得发明专利授权:“移液工作站”
海尔生物获得实用新型专利授权:“细胞培养工作站”
证券之星 · 10-31
海尔生物获得实用新型专利授权:“细胞培养工作站”
股市必读:海尔生物(688139)10月28日董秘有最新回复
证券之星 · 10-29
股市必读:海尔生物(688139)10月28日董秘有最新回复
海尔生物:10月27日接受机构调研,WCM Investment Management、东方证券等多家机构参与
证券之星 · 10-28
海尔生物:10月27日接受机构调研,WCM Investment Management、东方证券等多家机构参与
加载更多
公司概况
公司名称:
青岛海尔生物医疗股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-10-25
主营业务:
青岛海尔生物医疗股份有限公司的主营业务是为生物医药企业、高校科研机构、医院、疾控等用户提供数字化场景解决方案。公司的主要产品是智慧平台、样本存储、药品、疫苗存储、血液存储。根据全球权威调研机构欧睿国际(Euromonitor)认证,公司已经成为“全球生命科学实验室设备中国自主品牌销售额第一”及“生命科学实验室设备中国自主品牌海外销售额第一”。
发行价格:
15.53
{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"海尔生物","latestPrice":29.79,"timestamp":1795158000000,"preClose":30.36,"halted":0,"volume":3576071,"delay":0,"changeRate":-0.0188,"floatShares":316000000,"shares":316000000,"eps":0.8596,"marketStatus":"已收盘","change":-0.57,"latestTime":"11-20 15:00:00","open":30,"high":30.36,"low":29.28,"amount":107000000,"amplitude":0.0356,"askPrice":29.79,"askSize":81,"bidPrice":29.68,"bidSize":12,"shortable":0,"etf":0,"ttmEps":0.8596,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":30.36,"symbolType":"stock_kcb","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":33.4,"lowLimit":27.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":2.09,"roa":"--","peRate":34.655654,"roe":"4.95%","epsLYR":0.8,"committee":0.028112,"marketValue":9428000000,"turnoverRate":0.0113,"status":1,"afterMarket":{"amount":0,"volume":0,"close":29.79,"buyVolume":0,"sellVolume":0,"time":1795160037746,"indexStatus":"已收盘 11-20 15:30:00","preClose":30.36},"floatMarketCap":9428000000},"requestUrl":"/m/hq/s/688139","defaultTab":"news","newsList":[{"id":"2684846948","title":"海尔生物(688139)11月18日主力资金净卖出24.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684846948","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684846948?lang=zh_cn&edition=full","pubTime":"2026-11-19 08:29","pubTimestamp":1795048183,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月18日收盘,海尔生物报收于30.36元,下跌3.74%,换手率1.12%,成交量3.54万手,成交额1.08亿元。近5日资金流向一览见下表:海尔生物融资融券信息显示,融资方面,当日融资买入744.22万元,融资偿还723.17万元,融资净买入21.04万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111900007124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684916286","title":"股市必读:海尔生物(688139)11月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2684916286","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684916286?lang=zh_cn&edition=full","pubTime":"2026-11-19 04:00","pubTimestamp":1795032048,"startTime":"0","endTime":"0","summary":"截至2026年11月18日收盘,海尔生物报收于30.36元,下跌3.74%,换手率1.12%,成交量3.54万手,成交额1.08亿元。董秘最新回复投资者: 董秘您好!公司已将科技伦理纳入治理体系,通过制定《科技伦理与治理制度》对研发活动进行伦理规范与审查,详情请参考《海尔生物2025年可持续发展报告》。当日关注点交易信息汇总:11月18日主力资金净流出24.58万元,占总成交额0.23%;游资资金净流入779.3万元,占总成交额7.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111900003648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684968797","title":"海尔生物:已将科技伦理纳入治理体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2684968797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684968797?lang=zh_cn&edition=full","pubTime":"2026-11-18 15:33","pubTimestamp":1794987199,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物11月18日在投资者关系平台上答复投资者关心的问题。关注到公司主营专用设备与零部件,ESG报告中披露了科技伦理治理架构与伦理审查制度。公司已将科技伦理纳入治理体系,通过制定《科技伦理与治理制度》对研发活动进行伦理规范与审查,详情请参考《海尔生物2025年可持续发展报告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800025108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684938565","title":"股市必读:海尔生物(688139)11月17日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2684938565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684938565?lang=zh_cn&edition=full","pubTime":"2026-11-18 02:17","pubTimestamp":1794939431,"startTime":"0","endTime":"0","summary":"截至2026年11月17日收盘,海尔生物报收于31.54元,上涨1.22%,换手率0.98%,成交量3.11万手,成交额9774.64万元。机构调研要点:2026年前三季度公司低温产业同比增长12%,已连续5个季度同比正增长;智慧实验室方案在手订单接近千万,超亿元商机开始转化;主导的自动化医用冷库IEC国际标准正式立项,为全球首个相关国际标准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800001109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684498352","title":"海尔生物:11月17日接受机构调研,航长投资、中金公司参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2684498352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684498352?lang=zh_cn&edition=full","pubTime":"2026-11-17 21:01","pubTimestamp":1794920515,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年11月17日海尔生物发布公告称公司于2026年11月17日接受机构调研,航长投资、中金公司参与。以公司常年服务的全球某头部CXO企业为例,截至今年三季度其采购金额相比去年全年大幅增长。实验室解决方案的增长来自国产替代、出海扩张以及公司用户渠道的持续丰富,带动整体实验室解决方案产业第三季度同比增长35%,累计同比增长24%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700040895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","LU2929501877.USD","LU1580142542.USD","LU2187417386.USD","LU2351347302.SGD","LU0359201885.HKD","LU2663582299.SGD","SG9999002828.SGD","BK1516","LU1781817850.SGD","BK1564","03908","LU0359202008.SGD","LU0359201612.USD","LU2488822045.USD","BK0251","BK1147","LU1023057109.AUD","688139","BK1501","601995","LU1508157978.USD","LU0259732245.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2682597535","title":"【机构调研记录】新华基金调研海尔生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2682597535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682597535?lang=zh_cn&edition=full","pubTime":"2026-11-12 08:01","pubTimestamp":1794441704,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月11日披露的机构调研信息,新华基金近期对1家上市公司进行了调研,相关名单如下:1)海尔生物 调研纪要:2026年第三季度,公司低温产业同比增长10%,实验室解决方案、智慧用药和血液技术产业分别增长35%、24%和19%,业务结构转向四大产业协同发展。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200006116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682370316","title":"海尔生物(688139)11月10日股东户数1.41万户,较上期减少0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682370316","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682370316?lang=zh_cn&edition=full","pubTime":"2026-11-11 17:44","pubTimestamp":1794390289,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年11月10日公司股东户数为1.41万户,较10月31日减少132.0户,减幅为0.93%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至11月10日,医疗器械行业平均股东户数为2.11万户。从股价来看,2026年10月31日至2026年11月10日,海尔生物区间涨幅为6.1%,在此期间股东户数减少132.0户,减幅为0.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100035591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682036376","title":"海尔生物:截至2026年11月10日,公司股东总数为14,096户","url":"https://stock-news.laohu8.com/highlight/detail?id=2682036376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682036376?lang=zh_cn&edition=full","pubTime":"2026-11-11 15:34","pubTimestamp":1794382446,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司最新一期的股东户数是多少?谢谢海尔生物回复:尊敬的投资者您好,截至2026年11月10日,公司股东总数为14,096户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100026880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681811822","title":"治疗进入细胞时代!海尔生物以AI与低温创新引领产业变革","url":"https://stock-news.laohu8.com/highlight/detail?id=2681811822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681811822?lang=zh_cn&edition=full","pubTime":"2026-11-07 15:03","pubTimestamp":1794034997,"startTime":"0","endTime":"0","summary":"医学治疗正在加速进入细胞时代。以CAR-T为代表的细胞治疗,让细胞本身成为治疗疾病的重要载体。面向造血干细胞等高价值细胞材料的冻存需求,海尔生物在本届进博会上首发首展Servita原位程序降温存储工作站,将程序降温与80℃低温存储集成于同一设备。海尔生物的原创低温创新还延伸至196℃液氮存储领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026110700014002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680553056","title":"海尔生物:11月3日接受机构调研,宝盈基金、国盛证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2680553056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680553056?lang=zh_cn&edition=full","pubTime":"2026-11-04 20:10","pubTimestamp":1793794252,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年11月4日海尔生物发布公告称公司于2026年11月3日接受机构调研,宝盈基金、国盛证券、太平养老、长江证券参与。以公司常年服务的全球某头部CXO企业为例,截至今年三季度其采购金额相比去年全年大幅增长。该股最近90天内共有5家机构给出评级,买入评级2家,增持评级3家;过去90天内机构目标均价为47.0。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400037595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0052","002670","LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680708160","title":"海尔生物新注册《高通量器官芯片微肿瘤药敏测试人工智能平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2680708160","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680708160?lang=zh_cn&edition=full","pubTime":"2026-11-04 05:40","pubTimestamp":1793742026,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物(688139)新注册了《高通量器官芯片微肿瘤药敏测试人工智能平台V1.0》项目的软件著作权。今年以来海尔生物新注册软件著作权16个,较去年同期减少了36%。结合公司2026年中报财务数据,今年上半年公司在研发方面投入了1.72亿元,同比增7.74%。通过天眼查大数据分析,青岛海尔生物医疗股份有限公司共对外投资了17家企业,参与招投标项目3732次;财产线索方面有商标信息610条,专利信息2033条,著作权信息149条;此外企业还拥有行政许可46个。数据来源:企查查以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400006758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161631","159180","688139","159813","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680791117","title":"股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680791117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680791117?lang=zh_cn&edition=full","pubTime":"2026-11-04 02:42","pubTimestamp":1793731332,"startTime":"0","endTime":"0","summary":"股本股东变化:截至2026年10月31日,海尔生物股东户数为1.42万户,较10月20日减少0.83%。公司公告汇总海尔生物关于以集中竞价交易方式回购公司股份的进展公告青岛海尔生物医疗股份有限公司于2026年7月20日至2027年7月19日实施股份回购,拟回购金额为5,000万元至10,000万元,用于减少注册资本;截至2026年10月31日,已累计回购股份2,511,592股,占公司总股本的0.7936%,回购最高价为34.10元/股,最低价为28.15元/股,支付资金总额为78,946,912.63元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400004305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680740881","title":"海尔生物(688139)10月31日股东户数1.42万户,较上期减少0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680740881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680740881?lang=zh_cn&edition=full","pubTime":"2026-11-03 19:10","pubTimestamp":1793704252,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年10月31日公司股东户数为1.42万户,较10月20日减少119.0户,减幅为0.83%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至10月31日,医疗器械行业平均股东户数为2.11万户。从股价来看,2026年10月20日至2026年10月31日,海尔生物区间跌幅为5.45%,在此期间股东户数减少119.0户,减幅为0.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300037209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680743908","title":"海尔生物:截至2026年10月31日,公司股东总数为14,228户","url":"https://stock-news.laohu8.com/highlight/detail?id=2680743908","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680743908?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:06","pubTimestamp":1793693171,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问:您好!请问截至10月底公司股东人数是多少,谢谢!海尔生物回复:尊敬的投资者您好,截至2026年10月31日,公司股东总数为14,228户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300030160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680763796","title":"海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,11月02日股价上涨1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680763796","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680763796?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:23","pubTimestamp":1793629426,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘,海尔生物报收于31.19元,较前一交易日上涨1.66%,最新总市值为98.71亿元。该股当日开盘30.7元,最高31.5元,最低30.65元,成交额达1.16亿元,换手率为1.18%。近日,海尔生物发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示,公司于2026年7月20日至2027年7月19日实施股份回购,拟回购金额为5,000万元至10,000万元,用于减少注册资本。本次回购符合相关法规及公司方案规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200036909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680754445","title":"海尔生物已回购约251.16万股,耗资约7894.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680754445","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680754445?lang=zh_cn&edition=full","pubTime":"2026-11-02 20:15","pubTimestamp":1793621700,"startTime":"0","endTime":"0","summary":"北京商报讯(记者董亮实习记者张天藉)11月2日晚间,海尔生物(688139)披露公告称,截至10月31日,公司通过上交所交易系统以集中竞价交易方式累计回购公司股份约251.16万股,占公司总股本约0.7 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261102/c681371369.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261102/c681371369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680200814","title":"海尔生物获得发明专利授权:“移液工作站”","url":"https://stock-news.laohu8.com/highlight/detail?id=2680200814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680200814?lang=zh_cn&edition=full","pubTime":"2026-11-02 03:59","pubTimestamp":1793563183,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示海尔生物新获得一项发明专利授权,专利名为“移液工作站”,专利申请号为CN202311134885.X,授权日为2026年10月30日。本发明的移液工作站在回收废弃的移液枪和废液的过程中能够避免对未使用的耗材造成污染,有效保证移液过程的生物安全。今年以来海尔生物新获得专利授权126个,较去年同期增加了63.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679223451","title":"海尔生物获得实用新型专利授权:“细胞培养工作站”","url":"https://stock-news.laohu8.com/highlight/detail?id=2679223451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679223451?lang=zh_cn&edition=full","pubTime":"2026-10-31 06:28","pubTimestamp":1793399304,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示海尔生物新获得一项实用新型专利授权,专利名为“细胞培养工作站”,专利申请号为CN202522293890.6,授权日为2026年10月30日。今年以来海尔生物新获得专利授权116个,较去年同期增加了50.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100012288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679225419","title":"股市必读:海尔生物(688139)10月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2679225419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679225419?lang=zh_cn&edition=full","pubTime":"2026-10-29 04:10","pubTimestamp":1793218218,"startTime":"0","endTime":"0","summary":"截至2026年10月28日收盘,海尔生物报收于32.3元,上涨2.18%,换手率1.12%,成交量3.54万手,成交额1.14亿元。公司董事和高级管理人员的详细信息具体请见《海尔生物2025年年度报告》第四节“公司治理、环境和社会”。当日关注点交易信息汇总:10月28日主力资金净流出121.49万元,散户资金净流入269.21万元。国内市场第三季度新突破近30家药企,累计覆盖国内TOP100药企50家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900004864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678746130","title":"海尔生物:10月27日接受机构调研,WCM Investment Management、东方证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2678746130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678746130?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:13","pubTimestamp":1793186006,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年10月28日海尔生物发布公告称公司于2026年10月27日接受机构调研,WCM Investment Management、东方证券、富国基金、广发基金、国联民生证券、华夏基金、万家基金、兴业基金、中信证券参与。国内市场方面,制药终端的用户研发和生产的高景气度延续,以公司常年服务的全球某头部CXO企业为例,截至今年三季度其采购金额相比去年全年大幅增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800042514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1564","BK0012","LU2488822045.USD","BK0028","BK0188","BK1147","03958","600958","BK0183","BK0276","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795186122386,"stockEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.0644},{"period":"3month","weight":0.0278},{"period":"6month","weight":-0.1647},{"period":"1year","weight":-0.0857},{"period":"ytd","weight":-0.033}],"compareEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0422},{"period":"3month","weight":-0.0839},{"period":"6month","weight":-0.1301},{"period":"1year","weight":-0.0935},{"period":"ytd","weight":-0.0986}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"14096人(较上一季度减少0.93%)","perCapita":"22452股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":" 青岛海尔生物医疗股份有限公司的主营业务是为生物医药企业、高校科研机构、医院、疾控等用户提供数字化场景解决方案。公司的主要产品是智慧平台、样本存储、药品、疫苗存储、血液存储。根据全球权威调研机构欧睿国际(Euromonitor)认证,公司已经成为“全球生命科学实验室设备中国自主品牌销售额第一”及“生命科学实验室设备中国自主品牌海外销售额第一”。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海尔生物,688139,海尔生物股票,海尔生物股票老虎,海尔生物股票老虎国际,海尔生物行情,海尔生物股票行情,海尔生物股价,海尔生物股市,海尔生物股票价格,海尔生物股票交易,海尔生物股票购买,海尔生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}